Tags : Innovation

ViewPoints Interview: Paige’s CEO, Leo Grady Shares Insights on its

Paige is a global digital pathology founded in 2017 by Thomas Fuchs, Dr. Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The company involves computational pathology products that are targeted for patients and their care teams for effective, more informed treatment decisions. Paige has developed a platform to deliver novel technology to pathologists to […]Read More

Paige Secures Funding from Goldman Sachs to Continue Innovation in

Shots: Paige has completed a $70M series B funding round that included $15M in additional investment from Goldman Sachs Merchant Banking Division. The firm has so far invested $20M in Paige Additionally, Healthcare Venture has also invested $5M bringing Paige’s total capital raised to over $95M.  Paige will utilize its funding to ramp up its […]Read More

PharmaShots: COVID-19 Healthcare News Monthly Updates – June 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More

Insights+: COVID-19 Healthcare News Monthly Updates – May 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 virus has been named “SARS-CoV-2” (severe acute respiratory syndrome coronavirus 2) and the disease it causes has been named “Coronavirus Disease 2019” (COVID-19). The outbreak of the respiratory disease was first detected […]Read More

­WHO to Accelerate Global Research and Innovation Against Corona Virus

Shots: WHO convoke global research and innovation forum to be held on Feb 11-12, 2020 in Geneva for mobilization of international action in response to the coronavirus (2019-nCoV) and is organized in collaboration with the Global Research Collaboration for Infectious Disease Preparedness The forum will involve scientist, public health agencies, ministries of health and research […]Read More

Sanofi Divulges its Strategic Framework to Drive Innovation and Growth

Shots: Sanofi reveals its focus on its key growth drivers including Dupixent (dupilumab), vaccines and its pipeline consisting of six potentially transformative therapies. The company is expecting Dupixent to generate ~$11B in its annual sales Sanofi also reveals its six investigational therapies which include Fitusiran, BIVV001, Venglustat, SERD (‘859), Nirsevimab, BTKi (‘168) and plan its […]Read More